Renovaro Biosciences
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Renovaro Biosciences's balance sheet done over the years? Its assets were worth $163,129,450 last year, which is less than in the previous period. 19% of Renovaro Biosciences’s total assets is currently financed by debt. Its liabilities reached the amount of $31,152,306, which means an increase by 31% compared compared to last year.
Debt to Assets
| 2014 | 5239909 | 1.75M | 33.54% |
|---|---|---|---|
| 2016 | 870831 | 1.50M | 173.19% |
| 2018 | 182502456 | 23.76M | 13.02% |
| 2024 | 163129450 | 31.15M | 19.1% |
RENB Balance Sheet (2014 – 2023)
| 2023 | 2017 | 2015 | 2014 | |
|---|---|---|---|---|
Assets | ||||
Current assets: | ||||
Cash and cash equivalents | 220.46K | 15.60M | 23.36K | 3.00M |
Short term investments | 0 | 0 | 0 | 0 |
Net receivables | 1.10M | 122.86K | 695.41K | 8.01K |
Inventory | 0 | 0 | 0 | 0 |
Other current assets | 668.92K | 38.28K | 13.69K | 2.02M |
Total current assets | 1.99M | 15.76M | 732.47K | 5.04M |
Non-current assets: | ||||
Property, Plant and Equipment | 1.75M | 27.40K | 0 | 0 |
Goodwill | 159.33M | 11.64M | 0 | 0 |
Intangible assets | 30.04K | 0 | 0 | 186.41K |
Long term investments | 0 | 0 | 0 | 0 |
Other non-current assets | 19.84K | 155.07M | 138.35K | 7.14K |
Total non-current assets | 161.13M | 166.74M | 138.35K | 193.56K |
Total assets | 163.12M | 182.50M | 870.83K | 5.23M |
Liabilities | ||||
| Current liabilities: | ||||
Accounts payable | ||||
Deferred revenue | 231.38K | 0 | 0 | 0 |
Short term debt | 2.94M | 0 | 102.88K | 99.95K |
Total current liabilities | 30.30M | 873.72K | 1.50M | 1.75M |
| Non-current liabilities: | ||||
Long term debt | 842.38K | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 |
Other non-current liabilities | 0 | 22.89M | 0 | 0 |
Total non-current liabilities | 842.38K | 22.89M | 0 | 0 |
Total liabilities | 31.15M | 23.76M | 1.50M | 1.75M |
| Data source |